Lucid Diagnostics Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lucid Diagnostics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $0.00.
- Lucid Diagnostics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $210.00K, a 48.94% increase year-over-year.
- Lucid Diagnostics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $0.00.
- Lucid Diagnostics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $131.00K, a 39.36% increase year-over-year.
- Lucid Diagnostics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $272.00K, a 39.15% decline from fiscal 2024.
- Lucid Diagnostics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $447.00K, a 18.87% decline from fiscal 2023.
- Lucid Diagnostics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $551.00K, a 405.50% increase from fiscal 2022.
- Lucid Diagnostics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $109.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $341.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $210.00K 10-Q · filed 2026-05-13 | $341.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $272.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $131.00K 10-Q · filed 2025-11-12 | $272.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $235.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $141.00K 10-Q · filed 2026-05-13 | $235.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $447.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $94.00K 10-Q · filed 2025-11-12 | $447.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $628.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $353.00K 10-Q · filed 2025-05-13 | $628.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $551.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $275.00K 10-Q · filed 2024-11-12 | $551.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $385.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $276.00K 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $109.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $109.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |